These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10511359)
1. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Lennon CA; Gray DL Obstet Gynecol; 1999 Oct; 94(4):562-6. PubMed ID: 10511359 [TBL] [Abstract][Full Text] [Related]
3. Routine measurement of amniotic fluid alpha-fetoprotein and acetylcholinesterase: the need for a reevaluation. Flick A; Krakow D; Martirosian A; Silverman N; Platt LD Am J Obstet Gynecol; 2014 Aug; 211(2):139.e1-6. PubMed ID: 24530818 [TBL] [Abstract][Full Text] [Related]
4. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients. Richards DS; Seeds JW; Katz VL; Lingley LH; Albright SG; Cefalo RC Obstet Gynecol; 1988 Feb; 71(2):203-7. PubMed ID: 2447540 [TBL] [Abstract][Full Text] [Related]
5. Value of maternal serum alpha-fetoprotein levels of 5.0 MOM or greater and prenatal sonography in predicting fetal outcome. Larson JM; Pretorius DH; Budorick NE; Scioscia AL Radiology; 1993 Oct; 189(1):77-81. PubMed ID: 7690492 [TBL] [Abstract][Full Text] [Related]
6. Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds? Roman AS; Gupta S; Fox NS; Saltzman D; Klauser CK; Rebarber A Fetal Diagn Ther; 2015; 37(3):206-10. PubMed ID: 25034077 [TBL] [Abstract][Full Text] [Related]
7. Role of ultrasound and informed consent in the evaluation of elevated maternal serum alpha-fetoprotein. Katz VL; Seeds JW; Albright SG; Lingley LH; Lincoln-Boyea B Am J Perinatol; 1991 Mar; 8(2):73-6. PubMed ID: 1706599 [TBL] [Abstract][Full Text] [Related]
8. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991. Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023 [TBL] [Abstract][Full Text] [Related]
9. Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results. Lindfors KK; McGahan JP; Tennant FP; Hanson FW; Walter JP AJR Am J Roentgenol; 1987 Jul; 149(1):141-5. PubMed ID: 2438918 [TBL] [Abstract][Full Text] [Related]
10. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects. Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442 [TBL] [Abstract][Full Text] [Related]
11. Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations. Nadel AS; Green JK; Holmes LB; Frigoletto FD; Benacerraf BR N Engl J Med; 1990 Aug; 323(9):557-61. PubMed ID: 1696358 [TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects. Papp Z; Tóth Z; Török O; Szabó M Am J Med Genet; 1987 Jan; 26(1):103-10. PubMed ID: 2433941 [TBL] [Abstract][Full Text] [Related]
13. The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects. Hogge WA; Thiagarajah S; Ferguson JE; Schnatterly PT; Harbert GM Am J Obstet Gynecol; 1989 Sep; 161(3):520-3; discussion 523-4. PubMed ID: 2476929 [TBL] [Abstract][Full Text] [Related]
14. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome. Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005 [TBL] [Abstract][Full Text] [Related]